Joe Neighbour has been tracking GlaxoSmithKline, a big pharma stock that seems to be in a...

Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

This week the New York Times, in an editorial, urged US lawmakers to legalise marijuana. Some...

Serge Berger suggests buying Biogen, a biotech firm which has reported sales of its Multiple...

AstraZeneca’s stock price tumbled 14 percent on Monday morning after the company rejected...

As the Astra Zeneca Pfizer deal gets more bad tempered and political, what are the side effects...

Leading Bio tech firms, have seen around thirty percent growth in the last year and prospects...

The boss of British pharmaceutical giant AstraZeneca, Pascal Soriot, has been emphasising the...

Johnson Johnson Co. pharmaceuticals division has pushed first quarter profits past analysts’...